Method of reducing insulin dosage in diabetic patients using stem cell therapy
A technology of stem cell therapy and diabetes, applied in animal cells, vertebrate cells, bone/connective tissue cells, etc., can solve the problems of insulin edema, easy identification, and elevated blood sugar, so as to reduce the dosage and reduce various side effects Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0016] The present invention will be described in detail below with reference to specific embodiments.
[0017] The invention discloses a method for reducing the insulin dosage of diabetic patients by applying stem cell therapy. The method is to separate and expand the bone marrow mesenchymal stem cells in the diabetic patients, cultivate mature bone marrow mesenchymal stem cells, and then re-interstitial the mesenchymal stem cells. Mesenchymal stem cells are injected back into diabetic patients to reduce the dosage of insulin in diabetic patients. The infusion method is intravenous injection. The average amount of mesenchymal stem cells per injection per patient is 11.2×10 10 One, inject once every 10 days. After each reinfusion, diabetic patients gradually reduce the amount of insulin, a total of 8 to 10 times, and increase the number of reinfusions according to the condition of the diabetic patient, until the diabetic patient can wean off insulin.
[0018] The method for re...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap